about
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's WitnessHuman artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblastsBlood management and patient specific transfusion options in total joint replacement surgeryUnderstanding cytokines. Part I: Physiology and mechanism of action.Bloodless medicine: clinical care without allogeneic blood transfusion.Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines.Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative periodPharmacotherapy of anaemia in cancer patients.Erythropoietin after a century of research: younger than ever.Evaluation and management of anemia in the elderlyBlood boostingAutologous blood donation.Preoperative recombinant human erythropoietin in anemic surgical patients.Aortic valve replacement in a Jehovah's Witness: a case of multi-disciplinary clinical management for bloodless surgery.Preoperative erythropoietin in spine surgery.Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.Iron supplementation for postoperative anaemia following major paediatric orthopaedic surgery.Erythropoietin and prematurity--where do we stand?Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyParenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patientsErythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialEfficient and regulated erythropoietin production by naked DNA injection and muscle electroporationTransfusion medicine and solid organ transplant - Update and review of some current issues.Anemia of thermal injury: combined acute blood loss anemia and anemia of critical illness.Effectiveness and safety of erythropoiesis-stimulating agent use in the perioperative period.Acute Normovolemic Hemodilution in Surgery.Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty.A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cranial bone.Liver transplantation in Jehovah's witnesses.Post-transfusion hepatitis: current risks and causes.Influence of clinical and economical factors on the expert rating of appropriateness of preoperative use of recombinant erythropoietin in elective orthopedic surgery patients.Managing anemia in the critically ill patient.Blood Transfusion Requirements in Otolaryngology-Head and Neck Surgery
P2860
Q28253693-CD99C745-6365-4FF5-B4E8-CA0FF0E28E00Q29036440-62E29B45-0922-4B2D-98FC-8F9A4497B039Q33997026-2FBC5A7D-291D-46BB-91D1-1A02DAE2A92BQ34171362-6FF2C4AB-BAC6-483C-B695-48D881F4F40DQ34191377-FF533AAD-5B20-4683-9910-F074E1708EA1Q34337012-544F4669-26A6-427B-AFCA-9C0826113F3AQ34385089-3DE73922-7707-4222-9F58-8E029586BFB5Q34399172-D85C5F31-EFD0-4FD0-9FF4-03FF8C5D66D3Q34492729-49D594C7-7212-4635-807D-B6919A07793BQ34515556-062D5B3B-2AB8-424A-B3CA-4E72049608C4Q34606348-D4051970-5B48-48D6-988E-1EB40F9C9B56Q34893552-5FA43FA5-F1F2-411D-B81E-BD9612976D5BQ35327374-7C0DBEA9-BCA9-4D53-9B51-357BC45BD81CQ35578979-78B93FF4-F264-4F76-BD99-2810C17DF783Q35579000-18ABB447-02BF-4163-BFAB-DFAD52F472DCQ35792538-D079B235-B6C6-4E81-8DE1-0C96DAB951C4Q35805534-0B3BD852-CEF7-48EE-A3F1-72F1F3F83375Q35851261-D4D4D343-0B8E-4BD3-8F52-507C24098772Q35968519-CAC9734B-40FC-4BC7-80DF-7289CB5B42BAQ36277959-54B12749-D3CD-4F00-AFD3-B2FDA0F77CC6Q36947393-756138F0-C4C1-4FC5-8A9D-D681B4D07782Q37123216-E7908619-547E-43A2-8873-45D0E6B60993Q37152501-5518536C-DFC5-4A7A-86B8-BBE452DD8572Q37210391-AFB6ED72-41C2-4A4F-98D9-049A19947AD7Q37390956-1AF15A85-5523-45A9-AD0D-B92CCC5091C2Q37698174-FAF6F0A7-6FDA-4934-A1FA-2EB397EFD05DQ38161950-AD4A0DD6-64B0-4B60-8781-343B62299179Q38894046-E015D67A-C35C-4C74-9F3A-428F1FDEA5DDQ42078615-AEDBEE13-155C-4FE1-90B0-7E8943CE0C90Q42284132-28948BC5-1B3B-435A-BD2C-E9D2B0C6B71DQ42532323-7B6916D5-6065-43F9-9D5B-BDE23D140DF0Q46594249-F9360C82-85E0-4F36-9F5A-7BDC8510C885Q46757904-5A1DADDB-FFBD-4A93-AFBA-4082BA7FF8E1Q47750440-7CE6F9EF-DF0F-473F-A4C2-DF37626C14CEQ50803255-BF47078C-1476-4D2A-AC08-249693A8BC1BQ58244633-83FBBD8C-0D91-47B4-8D11-7BC8DE54F1E1
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Erythropoietin therapy.
@en
type
label
Erythropoietin therapy.
@en
prefLabel
Erythropoietin therapy.
@en
P2093
P1476
Erythropoietin therapy.
@en
P2093
Andriole GL
Goodnough LT
P304
P356
10.1056/NEJM199703273361307
P407
P577
1997-03-01T00:00:00Z